JW Therapeutics competitorsClear all

Neovii's top competitors include Eutilex.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Neovii
Neovii
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Eutilex
Eutilex
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
Founding Date
Founding Date
2003
Founding Date
2015
Type
Type
Private
Type
Public
Tags
Locations
Locations
Rapperswil-Jona, CH HQ
Gräfelfing, DE
Lexington, US
Locations
KR HQ
Employees
Employees
89
Employees
108
For sources of this data, please see the company profile

View company profiles

Eutilex
HQ
KR
Employees
108

Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.

View company